V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240007749 | 240004793 | 1.75 | null | Palliative (P) | 2015-04-26 | 2015-05-15 | Carboplatin + Etoposide IV 3 day | N | null | 240034521 | CARBOPLATIN + ETOPOSIDE |
| 240007750 | 240004794 | 1.85 | 74 | Palliative (P) | 2015-06-30 | 2015-07-08 | Chlorambucil | N | N | 240034522 | CHLORAMBUCIL |
| 240007751 | 240004795 | 1.68 | 87.4 | Curative (C) | 2013-08-12 | 2013-08-13 | INTERLACE TRIAL | 02 | N | 240034525 | INTERLACE TRIAL |
| 240007752 | 240004795 | 1.47 | 62 | Palliative (P) | 2015-06-10 | 2015-06-22 | null | 02 | N | 240034525 | NOT MATCHED |
| 240007753 | 240004796 | 1.61 | 59.8 | Palliative (P) | 2016-04-02 | 2016-04-09 | Chlorambucil | 02 | N | 240034531 | CHLORAMBUCIL |
| 240007754 | 240004797 | 1.62 | 83 | Disease modification (D) | 2018-02-03 | 2018-02-28 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034537 | CHLORAMBUCIL + RITUXIMAB |
| 240007755 | 240010659 | 1.67 | 56 | Disease modification (D) | 2015-02-02 | 2015-02-20 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034540 | CHLORAMBUCIL + RITUXIMAB |
| 240007756 | 240010659 | 1.66 | 55.4 | Disease modification (D) | 2013-06-19 | 2013-06-25 | CHLORAMBUCIL + RITUXIMAB | 01 | N | 240034540 | CHLORAMBUCIL + RITUXIMAB |
| 240007757 | 240004798 | 0 | 107 | Disease modification (D) | 2017-10-02 | 2017-10-03 | Hydroxycarbamide | 2 | N | 240034548 | HYDROXYCARBAMIDE |
| 240007758 | 240004799 | 1.53 | 104 | Palliative (P) | 2016-10-31 | 2016-11-03 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034550 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007759 | 240004799 | null | 96 | Curative (C) | 2017-04-01 | 2017-04-06 | DA 3 + 10 | N | Y | 240034550 | DA |
| 240007760 | 240004800 | 1.94 | null | Disease modification (D) | 2017-09-08 | 2018-01-14 | Chlorambucil | null | null | 240034558 | CHLORAMBUCIL |
| 240007761 | 240004801 | 1.74 | null | null | 2013-06-12 | 2013-06-24 | CYTARABINE + DAUNORUBICIN | N | N | 240034561 | DA |
| 240007762 | 240010661 | 1.67 | 48.4 | Disease modification (D) | 2017-10-29 | 2017-10-31 | SMILE | N | N | 240034563 | TRIAL |
| 240007763 | 240010661 | 1.5 | null | Palliative (P) | 2014-06-24 | 2014-07-02 | Carboplatin + Etoposide iv&po | N | N | 240034563 | CARBOPLATIN + ETOPOSIDE |
| 240007764 | 240010661 | 1.82 | 80.8 | null | 2017-09-14 | 2017-09-14 | ALCL ALCL 99 Closed Pre Phase | 02 | N | 240034563 | NOT MATCHED |
| 240007765 | 240010661 | 1.71 | 63.8 | Disease modification (D) | 2016-09-23 | 2016-10-01 | Bendamustine + prednisolone | 02 | N | 240034563 | BENDAMUSTINE |
| 240007766 | 240004802 | 1.51 | 62 | null | null | 2014-03-27 | R Chlorambucil | N | N | 240034575 | CHLORAMBUCIL + RITUXIMAB |
| 240007767 | 240004803 | null | 68 | Curative (C) | 2015-03-10 | 2015-03-13 | Carboplatin + Etoposide iv&po | 2 | N | 240034576 | CARBOPLATIN + ETOPOSIDE |
| 240007768 | 240004803 | null | 54 | Palliative (P) | 2014-07-13 | 2014-08-08 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | N | 240034576 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007769 | 240004804 | 1.72 | 75.2 | null | 2013-12-31 | 2014-01-02 | Chlorambucil | N | N | 240034580 | CHLORAMBUCIL |
| 240007770 | 240004805 | 0 | 0 | Neo-adjuvant (N) | 2016-12-06 | 2016-12-16 | INTERLACE TRIAL | N | N | 240034581 | INTERLACE TRIAL |
| 240007771 | 240004805 | 1.58 | 65 | Palliative (P) | 2017-05-24 | 2017-06-05 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 240034581 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007772 | 240004806 | 1.93 | 116 | Curative (C) | 2016-04-11 | 2016-04-14 | INTERLACE TRIAL | N | N | 240034583 | INTERLACE TRIAL |
| 240007773 | 240004806 | 1.75 | 90.5 | Curative (C) | 2013-11-16 | 2013-11-20 | Bendamustine +/- Prednisolone | N | N | 240034583 | BENDAMUSTINE |
| 240007774 | 240004807 | 1.62 | 64.7 | Curative (C) | 2015-01-16 | 2015-02-02 | INTERLACE TRIAL | 2 | N | 240034587 | INTERLACE TRIAL |
| 240007775 | 240004807 | 1.66 | null | Curative (C) | 2013-06-27 | 2013-07-13 | R Chlorambucil | N | N | 240034587 | CHLORAMBUCIL + RITUXIMAB |
| 240007776 | 240004808 | null | null | Curative (C) | null | 2013-10-27 | R Chlorambucil | N | N | 240034593 | CHLORAMBUCIL + RITUXIMAB |
| 240007777 | 240004808 | null | 61.5 | null | 2015-09-12 | 2015-09-13 | Chlorambucil | N | null | 240034593 | CHLORAMBUCIL |
| 240007778 | 240013550 | 1.54 | 91.65 | Curative (C) | 2013-08-06 | 2013-08-10 | SMILE | Y | null | 240034604 | TRIAL |
| 240007779 | 240013550 | 1.68 | 52.7 | Adjuvant (A) | null | 2018-01-11 | Carboplatin AUC 2 - 5 | N | N | 240034604 | CARBOPLATIN |
| 240007780 | 240004809 | null | 52 | Palliative (P) | null | 2017-05-08 | Chlorambucil | 02 | N | 240034613 | CHLORAMBUCIL |
| 240007781 | 240010667 | 1.63 | 65.5 | Curative (C) | 2015-12-18 | 2015-12-18 | Carboplatin AUC 2 - 5 | 02 | N | 240034614 | CARBOPLATIN |
| 240007782 | 240010667 | 1.66 | 55 | Palliative (P) | 2013-04-03 | 2013-04-19 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 240034614 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007783 | 240004810 | 1.6 | null | Curative (C) | 2013-08-23 | 2013-08-24 | Bendamustine +/- Prednisolone | 02 | null | 240034620 | BENDAMUSTINE |
| 240007784 | 240004811 | 1.79 | 77 | null | 2013-09-02 | 2013-09-08 | CARBOPLATIN | N | N | 240034622 | CARBOPLATIN |
| 240007785 | 240010668 | 1.87 | null | Curative (C) | 2014-06-09 | 2014-06-09 | Hydroxycarbamide | null | null | 240034631 | HYDROXYCARBAMIDE |
| 240007786 | 240004812 | null | 98.7 | Curative (C) | 2015-06-08 | 2015-06-09 | CYTARABINE + DAUNORUBICIN | N | null | 240034645 | DA |
| 240007787 | 240004813 | 1.78 | 67 | Palliative (P) | 2017-04-09 | 2017-05-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | 240034649 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007788 | 240004814 | 1.69 | 65 | Neo-adjuvant (N) | 2014-07-04 | 2014-07-12 | INTERLACE TRIAL | N | N | 240034657 | INTERLACE TRIAL |
| 240007789 | 240004814 | 1.62 | 59.7 | Adjuvant (A) | 2014-10-22 | 2014-11-17 | CARBOPLATIN | N | N | 240034657 | CARBOPLATIN |
| 240007790 | 240004814 | null | null | Disease modification (D) | 2015-03-13 | 2015-03-14 | Hydroxycarbamide | 2 | N | 240034657 | HYDROXYCARBAMIDE |
| 240007791 | 240004815 | 0 | 0 | Palliative (P) | 2015-09-24 | 2015-10-22 | Bevacizumab+Carbo+Pacliaxel | N | N | 240034661 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240007792 | 240004816 | 1.68 | 99.5 | Palliative (P) | 2017-08-07 | 2017-08-12 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 240034664 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 240007793 | 240010670 | 1.75 | 94.3 | Palliative (P) | 2013-11-20 | 2013-11-21 | Hydroxycarbamide | N | N | 240034669 | HYDROXYCARBAMIDE |
| 240007794 | 240010670 | 1.58 | 48 | Palliative (P) | 2016-04-15 | 2016-04-25 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034669 | CHLORAMBUCIL + RITUXIMAB |
| 240007795 | 240004817 | 1.75 | null | Palliative (P) | null | 2015-09-30 | CHLORAMBUCIL + RITUXIMAB | N | N | 240034672 | CHLORAMBUCIL + RITUXIMAB |
| 240007796 | 240004817 | 1.87 | 88.5 | Palliative (P) | 2013-12-25 | 2013-12-26 | Chlorambucil | N | N | 240034672 | CHLORAMBUCIL |
| 240007797 | 240004817 | 1.73 | 58 | Curative (C) | 2017-07-06 | 2017-07-06 | Carboplatin AUC 6 - 10 | Y | null | 240034672 | CARBOPLATIN |
| 240007798 | 240004818 | 1.57 | 94.3 | Palliative (P) | null | 2016-01-19 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 240034683 | BEVACIZUMAB + CARBO + PACLITAXEL |